SUBSCRIBE

Breaking News on Biopharmaceutical Development & Manufacturing

All news > Audio

Bioproduction bottlenecks increasing due to staff shortages, says report

Bioprocessing bottlenecks increasing due to staff shortages, report

Eric Langer

Managing partner - BioPlan Associates

A shortage in expertise is causing bottlenecks in the biomanufacturing space with around half of drugmakers struggling to fill processing positions, an industry report finds.

Published: 16-Aug-2017

'The sexiness of the ADC world' - CMOs talk antibody-drug hybrids at CPhI

'The sexiness of the ADC world' - CMOs talk antibody-drug hybrids at CPhI

Piramal’s COO Vijay Shah described antibody-drug conjugates (ADCs) as “a concept whose time has come” at the CPhI annual report press conference and recent investors in the technology echo his words.

Published: 30-Oct-2013

Better single-use cross flow techs still needed says GE Healthcare

Better single-use cross flow techs still needed says GE Healthcare

Neil Ross

Marketing Manager - Bioprocess EMEA, Life Sciences - GE Healthcare

The biopharmaceutical manufacturing sector needs better cross flow filtration technologies according to GE Healthcare, which says that advances in bioreactor systems have not been matched downstream.

Published: 16-Oct-2013

Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech

Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech

James noble

CEO - Immunocore Ltd.

Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.

Published: 17-Jul-2013

Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal

Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal

ASI has teamed up with Chromatan in order to deliver single-use and column-free capture purification services which could save clients 65% in chromatography costs in clinical manufacturing.

Published: 30-Apr-2013

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

Special Report from ATMI's Belgian Facility

New innovations in single-use bioprocessing systems are being picked up quicker in Europe than in the US, according to ATMI.

Published: 20-Feb-2013

The single-use age has dawned, says ThermoFisher

The single-use age has dawned, says ThermoFisher

Bill Whitford

Senior manager of the bioprocessing market - ThermoFisher

Developments in single-use technology signals the end for clean-in-place biomanufacturing methods, according to ThermoFisher’s Bill Whitford.

Published: 21-May-2012

European CMO market will double in just 6 years, says Frost & Sullivan

European CMO market will double in just 6 years, says Frost & Sullivan

Aiswariya Chidambaram

Healthcare market analyst - Frost & Sullivan

The European CMO sector is set to double in the next six years and will hit revenues of up to $20.75bn, according to Frost & Sullivan’s Aiswariya Chidambaram.

Published: 15-Mar-2012

Acuros in talks with Big Pharma over water-powered delivery pump

Acuros in talks with Big Pharma over water-powered delivery pump

Helge Adleff

CEO - Acuros

Acuros is seeking development partnerships with Big Pharma over its recently launched water-powered drug delivery pump.

Published: 13-Mar-2012

Unilife launches Autoinfuser range publically

Unilife launches Autoinfuser range publically

Stephen Allan

VP of marketing and communications - Unilife

Unilife is expanding its large dose delivery platform in a bid to meet a “growing industry need” for at-home drug administration in bigger scale.

Published: 23-Feb-2012

An experienced CMO is key to successful biologics development says Cobra Biologics

An experienced CMO is key to successful biologics development says Cobra Biologics

Julian Hanak

Commercial director - Cobra Biologics

Detailed market knowledge and an experienced CMO are still critical to successfully developing a biopharmaceutical or biosimilar according to Cobra Biologics.

Published: 25-Jan-2012

EMD Millipore talks integration: of processes; and with owner Merck KGaA

EMD Millipore talks integration: of processes; and with owner Merck KGaA

Paul Chapman

Head of Biopharm Process Solutions - EMD Millipore

The biomanufacturing industry needs to adopt an integrated approach to upstream and downstream processing to boost efficiency and productivity according to EMD Millipore.

Published: 06-Apr-2011

SAFC preparing for inevitable shift to cell culture vaccines

SAFC preparing for inevitable shift to cell culture vaccines

David Backer

Director of Business Development and Marketing - SAFC Pharma

SAFC Pharma is preparing for the shift towards cell culture-based vaccines, while still supplying and growing in the traditional sector, to ensure it can grow in coming years, according to a company director.

Published: 25-Feb-2010

OctoPlus, Glycotope, Merck KGaA and SCM Pharma on BioPh 2009

OctoPlus, Glycotope, Merck KGaA and SCM Pharma on BioPh 2009

Gerben Moolhuizen, OctoPlus and Hans Baumeister, Glycotope

James Easson, Merk KGaA - Shirley Dann, SCM Pharma

How successful was the BioPh conference in Madrid? in-PharmaTechnologist asked key players attending the inaugural event.

Published: 29-Oct-2009

Gene therapy to drive viral and biologics market, says SAFC

Gene therapy to drive viral and biologics market, says SAFC

David Backer

Business development and marketing director - SAFC Pharma

SAFC Pharma has added extra viral and biologics capacity at its California plant in a $12m project that allows it to take projects from the lab to commercial scale.

Published: 14-Oct-2009

BIO 2009: snapshot of an evolving biotech industry

BIO 2009: snapshot of an evolving biotech industry

Nick Taylor

Science Reporter - in-PharmaTechnologist

in-Pharmatechnologist's Nick Taylor looks back on BIO 2009, an event at which uncertainty about the development of the biotechnology industry’s future shape dominated proceedings.

Published: 22-May-2009

France helps clusters battle for bio bucks

France helps clusters battle for bio bucks

Pierre Vimont

Ambassador to the US - France

HEM Pierre Vimont, Ambassador of France to the US, was at BIO 2009 talking about the measures his nation have taken to attract biotechs, including the introduction of the "most favourable R&D tax in Europe".

Published: 20-May-2009

Novartis comments on $490m cell-culture vaccine contract

Novartis comments on $490m cell-culture vaccine contract

Matt Stober

Spokesman - Novartis

Late last week the US Department of Health and Human Services (HHS) awarded Novartis a $490m contract to continue work on its cell-culture influenza vaccine plant in Holly Springs, North Carolina, US. in-PharmaTechnologist spoke with Novartis spokesman Matt Stober about the new plant.

Published: 21-Jan-2009

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...